Dexmedetomidine Protects Human Cardiomyocytes Against Ischemia-Reperfusion Injury Through α2-Adrenergic Receptor/AMPK-Dependent Autophagy

Background: Ischemia-reperfusion injury (I/R) strongly affects the prognosis of children with complicated congenital heart diseases (CHDs) who undergo long-term cardiac surgical processes. Recently, the α2-adrenergic receptor agonist Dexmedetomidine (Dex) has been reported to protect cardiomyocytes...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Pharmacol
Главные авторы: Xiao, Yingying, Li, Junpeng, Qiu, Lisheng, Jiang, Chuan, Huang, Yanhui, Liu, Jinfen, Sun, Qi, Hong, Haifa, Ye, Lincai
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Pharmacology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176440/
https://ncbi.nlm.nih.gov/pubmed/34093174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.615424
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы